Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in metastatic breast cancer. The FDA's approval supports dose optimization and ...

Atossa Therapeutics (ATOS) announced that the U.S. FDA issued a “Study May Proceed” letter for the company’s study in metastatic breast cancer ...

The peptide known as BPC‑157 (pentadecapeptide BPC-157) has garnered increasing attention across research domains ...

Severe alopecia areata may be driven by broader immune activation than previously recognized, according to new research ...

In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...

CDK2-mediated TBK1 degradation via Dtx4 represents a previously unrecognized regulatory mechanism that modulates antiviral immunity in fish.

To stay healthy, our cells rely on a self-cleaning mechanism that removes defective or unnecessary components. This process, ...

New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...

Maintaining cellular order is a major logistical challenge: Individual mammalian cells contain billions of protein molecules, ...